News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Metiscan, Inc. Subsidiary Schuylkill Open MRI, Inc. Sponsors Community Healthcare Events: Community Health Fair and 4th Annual American Red Cross Blood Drive


5/7/2009 10:49:08 AM

DALLAS, TX--(Marketwire - May 07, 2009) - Metiscan, Inc. (PINKSHEETS: MTIZ), a leading provider of products and services that streamline the management of diagnostic imaging facilities and an operator of diagnostic imaging facilities, today announced that its majority owned subsidiary Schuylkill Open MRI, Inc. (SOMRI), located in Pottsville, PA is sponsoring two community healthcare events during the months of June and July.

The first event is entitled "Care in our Community" and will be held on Wednesday, June 10, 2009 at 5:30pm. It will be held at the Fairlane Village Mall. Other event sponsors include ManorCare, Omni Home Health and Good Physical Therapy. There will be three local physicians speaking at the event to include Dr. John Chawluk, Dr. Carol Miller-Schaeffer and Dr. Myron Haas. Dr. Chawluk, a Neurologist, has been the Medical Director of SOMRI since 2003. He is a member of the American Board of Psychiatry and Neurology and Certification Examination, MRI/CT, by the American Society of Neuroimaging. Dr. Chawluk received his undergraduate degree at Harvard University, A.B., magna cum laude, in Biochemical Sciences and his MD from John Hopkins University School of Medicine. RSVP is required and seating is limited to 150 attendees.

The second event is SOMRI's Fourth Annual American Red Cross Blood Drive and will be held on Saturday, July 11, 2009, between 10:00am - 4:00pm. It will be held at the Fairlane Village Mall. Those who donate blood will be invited back to SOMRI for complimentary food and drinks. Scheduling an appointment in advance is strongly encouraged based on past drive attendance.

Shelley Tomey, SOMRI's Center Manager, commented, "I am really looking forward to both of these events. We have received positive feedback from both our referring physicians and patients alike." She further commented, "Sponsoring these events really demonstrates our commitment to our community and our commitment to patient care."

Metiscan acquired the majority interest in Schuylkill Open MRI, Inc. (SOMRI), (http://www.schuylkillopenmri.com/) on December 31st, 2008 through a share-for-share exchange. SOMRI is a diagnostic imaging facility that provides magnetic resonance imaging (MRI) services. SOMRI officially opened for business and began its operations in March of 2003 and is located in Pottsville, PA, a rural community located in Schuylkill County. SOMRI is accredited by the American College of Radiology (ACR).

About Metiscan, Inc.

Metiscan, Inc. is a national provider of products and services that streamline the management and operation functions of diagnostic imaging facilities, radiology groups, in-office imaging groups, small hospitals and physician offices and is an operator of a diagnostic MRI facility located in Pottsville, PA. Metiscan's keystone product is a web-based radiology information system that interfaces Radiology Information System (RIS), Teleradiology and PACS (Picture Archiving and Communication System) for its clients. Metiscan also provides information management and operations support for diagnostic imaging facilities through complete revenue cycle management, electronic health records or EHR, medical transcription services and functional training as needed.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.


Contact:
Investor Relations
David Donlin
Cervelle Group
Phone: 407-614-5955


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES